CYP27B1 and lung cancer: Determining whether 1αOHase is required for 25D3-mediated activity advances the clinical potential of dietary vitamin D3 supplementation because CYP27B1 expression is significantly decreased in EGFR mutant lung cancer cells under pressure of erlotinib treatment both in vitro and in vivo [19].